AGAPE ATP CORP

Agape ATP stock rises 0.65% to $1.42, trading 8.8k USD with 1M shares, while the pharma firm targets nutritional supplements to curb ulcers and cancer.

Agape ATP shares fall 0.64% to $1.54 amid a 31.88% YTD decline; 52‑week high $73.50, low $1.50. Explore the company’s Malaysia‑focused nutraceutical strategy and Nasdaq listing.